ArticleClinical rheumatology2026
Sex and age influence the association between insulin resistance and all-cause mortality in rheumatoid arthritis patients.
Article in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
objectivesTo investigate the association between insulin resistance (IR) and all-cause mortality among adults with rheumatoid arthritis (RA).
methodsIn this cohort study, we included 1,427 adults with self-reported RA from the National Health and Nutrition Examination Survey (NHANES) 1999-2010 and 2015-2018. IR was assessed using the homeostatic model assessment of insulin resistance (HOMA-IR). Survey-weighted multivariable Cox proportional hazards models were used to evaluate the association between HOMA-IR and all-cause mortality.
resultsDuring a mean follow-up of 9.7 years, 491 deaths occurred. Compared with participants in the lowest tertile of HOMA-IR, the multivariable-adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for all-cause mortality were 0.633 (0.466-0.860) and 0.626 (0.463-0.847) for the second and third tertiles, respectively. Each 1-standard deviation increase in HOMA-IR was associated with a 14.5% lower risk of all-cause mortality (HR 0.855, 95% CI 0.734-0.995). The association varied by age and sex. Stratified analyses suggested that higher HOMA-IR was associated with increased mortality risk in men aged < 70 years and women aged < 50 years, whereas inverse associations were observed in men aged ≥ 70 years and women aged ≥ 50 years.
conclusionsThe association between HOMA-IR and all-cause mortality among adults with RA differed according to age and sex. Although higher HOMA-IR was inversely associated with mortality overall, subgroup-specific associations were heterogeneous and should not be interpreted as evidence of a protective effect of IR. Further studies are needed to clarify the mechanisms underlying these age- and sex-related differences. Keypoints • This study provides the first nationally representative evidence on the association between HOMA-IR and all-cause mortality among U.S. adults reporting rheumatoid arthritis. • HOMA-IR showed an approximately L-shaped association with all-cause mortality. • The association differed by age and sex, with higher mortality risk in younger subgroups and inverse associations in older subgroups. • The findings remained consistent across multiple sensitivity analyses addressing medication use, C-reactive protein (CRP) assessment, missing data, and potential reverse causation.
Indexed as
Identifiers
42711633What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.